Published in Nature on November 13, 2013
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science (2014) 3.13
Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature (2015) 3.06
The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 2.32
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A (2014) 2.22
Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity (2014) 2.20
Gut Microbial Metabolites Fuel Host Antibody Responses. Cell Host Microbe (2016) 2.11
T cell metabolism drives immunity. J Exp Med (2015) 2.06
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature (2014) 2.03
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science (2017) 2.03
A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia (2015) 2.02
Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A (2014) 2.02
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med (2016) 1.96
MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells. Science (2015) 1.95
The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation. Immunity (2015) 1.79
Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol (2016) 1.75
Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med (2014) 1.69
A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature (2015) 1.62
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant (2014) 1.53
Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice. Cell Metab (2015) 1.51
Metabolism of stromal and immune cells in health and disease. Nature (2014) 1.49
Tissue adaptation of regulatory and intraepithelial CD4⁺ T cells controls gut inflammation. Science (2016) 1.49
The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites. Cell (2016) 1.47
Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol (2015) 1.44
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol (2017) 1.43
Finding the missing links among metabolites, microbes, and the host. Immunity (2014) 1.42
Sequencing and beyond: integrating molecular 'omics' for microbial community profiling. Nat Rev Microbiol (2015) 1.41
Inflammatory bowel disease as a model for translating the microbiome. Immunity (2014) 1.39
Teleost microbiomes: the state of the art in their characterization, manipulation and importance in aquaculture and fisheries. Front Microbiol (2014) 1.39
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One (2015) 1.36
The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis (2015) 1.33
The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33
Diet-microbiota interactions as moderators of human metabolism. Nature (2016) 1.31
Starving our microbial self: the deleterious consequences of a diet deficient in microbiota-accessible carbohydrates. Cell Metab (2014) 1.31
Gut dysbiosis is linked to hypertension. Hypertension (2015) 1.28
T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo. Immunity (2014) 1.28
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS. Acta Neuropathol (2015) 1.28
Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol (2014) 1.28
Targeting T cell metabolism for therapy. Trends Immunol (2015) 1.27
Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol (2015) 1.23
Gut microbiota, metabolites and host immunity. Nat Rev Immunol (2016) 1.22
Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun (2015) 1.21
Regulation of the immune system by the resident intestinal bacteria. Gastroenterology (2014) 1.19
Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients (2015) 1.18
The microbiota in adaptive immune homeostasis and disease. Nature (2016) 1.18
Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol (2014) 1.16
Breast-fed and bottle-fed infant rhesus macaques develop distinct gut microbiotas and immune systems. Sci Transl Med (2014) 1.16
Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat Rev Immunol (2016) 1.15
Alterations of the human gut microbiome in multiple sclerosis. Nat Commun (2016) 1.15
Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology (2014) 1.14
Standardised animal models of host microbial mutualism. Mucosal Immunol (2014) 1.13
Role of the normal gut microbiota. World J Gastroenterol (2015) 1.12
The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun (2015) 1.11
Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front Immunol (2014) 1.11
An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe (2015) 1.11
Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes (2014) 1.10
A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov (2014) 1.10
Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw (2014) 1.10
Hallmarks of Tissue-Resident Lymphocytes. Cell (2016) 1.10
Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol (2015) 1.08
Metabolic control of regulatory T cell development and function. Trends Immunol (2014) 1.06
Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis. J Immunol Res (2015) 1.06
Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med (2016) 1.05
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice. Cell Mol Gastroenterol Hepatol (2016) 1.05
Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. J Am Soc Nephrol (2014) 1.02
From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease. Cell (2015) 1.01
Treg functional stability and its responsiveness to the microenvironment. Immunol Rev (2014) 1.01
The gut microbiota and inflammatory bowel disease. Semin Immunopathol (2014) 1.01
Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia. Gut Microbes (2014) 1.00
Mining the human gut microbiota for effector strains that shape the immune system. Immunity (2014) 1.00
Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses. J Immunol (2014) 1.00
Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol (2015) 1.00
Control of Regulatory T Cell Migration, Function, and Homeostasis. J Immunol (2015) 1.00
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med (2016) 0.99
Interactions between the microbiota and pathogenic bacteria in the gut. Nature (2016) 0.99
Immune-microbiota interactions in health and disease. Clin Immunol (2015) 0.99
The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res (2014) 0.99
Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol (2014) 0.99
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes (2016) 0.99
Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol (2015) 0.98
Microbiota activation and regulation of innate and adaptive immunity. Immunol Rev (2014) 0.98
Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett (2014) 0.98
Diet is a major factor governing the fecal butyrate-producing community structure across Mammalia, Aves and Reptilia. ISME J (2015) 0.98
Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J (2015) 0.98
Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest (2014) 0.97
Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol (2016) 0.97
Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology (2016) 0.97
Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol (2016) 0.96
Microbial imbalance and intestinal pathologies: connections and contributions. Dis Model Mech (2014) 0.96
Fecal Transplants: What Is Being Transferred? PLoS Biol (2016) 0.95
Development and maintenance of intestinal regulatory T cells. Nat Rev Immunol (2016) 0.95
Tissue Tregs. Annu Rev Immunol (2016) 0.94
Early-life exercise may promote lasting brain and metabolic health through gut bacterial metabolites. Immunol Cell Biol (2015) 0.94
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med (2016) 0.94
Review: Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis Rheumatol (2016) 0.93
GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun (2015) 0.93
Commensal bacteria mediated defenses against pathogens. Curr Opin Immunol (2014) 0.93
Interactions Between the Gastrointestinal Microbiome and Clostridium difficile. Annu Rev Microbiol (2015) 0.93
The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol (2016) 0.93
Clustal W and Clustal X version 2.0. Bioinformatics (2007) 126.47
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics (2006) 14.96
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol (1993) 9.97
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity (2008) 9.82
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 9.81
Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol (2012) 9.75
Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol (2010) 9.72
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature (2009) 8.71
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature (2010) 6.87
Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 6.61
Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature (2010) 5.92
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 5.83
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem (2002) 5.53
Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity (2012) 4.98
Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity (2011) 4.86
Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature (2008) 4.42
Sodium butyrate inhibits histone deacetylation in cultured cells. Cell (1978) 4.20
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem (2007) 4.04
Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med (1989) 3.92
Inhibition of histone deacetylase activity by butyrate. J Nutr (2003) 3.84
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med (2012) 3.40
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med (2012) 2.97
Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity (2009) 2.84
Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc (2007) 2.75
Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity (2007) 2.57
The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology (2000) 2.27
PRIMe: a Web site that assembles tools for metabolomics and transcriptomics. In Silico Biol (2008) 2.22
Characterization of clostridia isolated from faeces of limited flora mice and their effect on caecal size when associated with germ-free mice. Lab Anim (1985) 2.12
Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology (2009) 1.81
Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res (2013) 1.78
Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal Chem (2010) 1.62
Stable isotope labeling of Arabidopsis thaliana for an NMR-based metabolomics approach. Plant Cell Physiol (2004) 1.59
Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J Nutr (2003) 1.42
Profiling polar and semipolar plant metabolites throughout extraction processes using a combined solution-state and high-resolution magic angle spinning NMR approach. Anal Chem (2010) 1.30
Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology (2007) 1.29
1H NMR metabolite fingerprinting and metabolomic analysis of perchloric acid extracts from plant tissues. Nat Protoc (2008) 1.25
Evaluation and characterization of bacterial metabolic dynamics with a novel profiling technique, real-time metabolotyping. PLoS One (2009) 1.18
Top-down phenomics of Arabidopsis thaliana: metabolic profiling by one- and two-dimensional nuclear magnetic resonance spectroscopy and transcriptome analysis of albino mutants. J Biol Chem (2007) 1.18
Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis. J Immunol (2012) 1.10
New monitoring approach for metabolic dynamics in microbial ecosystems using stable-isotope-labeling technologies. J Biosci Bioeng (2010) 1.05
DNA double-strand breaks induced by cavitational mechanical effects of ultrasound in cancer cell lines. PLoS One (2012) 1.01
Resistant proteins alter cecal short-chain fatty acid profiles in rats fed high amylose cornstarch. J Nutr (1998) 0.99
The influence of Staphylococcus aureus on gut microbial ecology in an in vitro continuous culture human colonic model system. PLoS One (2011) 0.94